Search
Patexia Research
Case number 1:19-cv-01336

Eisai Co., Ltd. et al v. Lupin Limited et al > Documents

Date Field Doc. No.Description (Pages)
Mar 10, 2020 14 Consent Judgment (3)
Docket Text: CONSENT JUDGMENT (see document for further information). Signed by Judge Leonard P. Stark on 3/9/20. (ntl)
Mar 6, 2020 13 Proposed Consent Judgment (3)
Docket Text: PROPOSED CONSENT JUDGMENT by Eisai Co., Ltd., Eisai Inc., Novartis Pharma AG. (Blumenfeld, Jack)
Feb 7, 2020 12 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Haney, Megan)
Feb 3, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [11] STIPULATION TO EXTEND TIME for Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. to answer, plead or otherwise respond to the Complaint (D.I. 1) to March 9, 2020 filed by Lupin Limited, Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 2/3/20. (ntl)
Feb 3, 2020 11 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. to answer, plead or otherwise respond to the Complaint (D.I. 1) to March 9, 2020 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John)
Jan 6, 2020 N/A SO ORDERED (0)
Jan 3, 2020 10 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to Answer, Plead or Otherwise Respond to the Complaint to February 7, 2020 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John)
Nov 25, 2019 N/A SO ORDERED (0)
Nov 22, 2019 9 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to ANSWER complaint to January 8, 2020 - filed by Eisai Co., Ltd., Eisai Inc., Novartis Pharma AG. (Raucci, Anthony)
Oct 15, 2019 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharma AG, Eisai Co., Ltd., Eisai Inc.: For Lupin Limited waiver sent on 10/10/2019, answer due 12/9/2019. (Raucci, Anthony)
Oct 15, 2019 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharma AG, Eisai Co., Ltd., Eisai Inc.: For Lupin Pharmaceuticals, Inc. waiver sent on 10/10/2019, answer due 12/9/2019. (Raucci, Anthony)
Jul 24, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (nms)
Jul 17, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 7/17/2019; Lupin Pharmaceuticals, Inc. on 7/17/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd)
Jul 17, 2019 1 Complaint (6)
Jul 17, 2019 1 Exhibit A (9)
Jul 17, 2019 1 Civil Cover Sheet (1)
Jul 17, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd)
Jul 17, 2019 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/25/2019. Date of Expiration of Patent: 5/14/2023.Thirty Month Stay Deadline: 12/25/2021. (kmd)
Jul 17, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (kmd)
Jul 17, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co., Ltd. for Eisai Co., Ltd., Eisai Inc. filed by Eisai Co., Ltd., Eisai Inc.. (kmd)
Jul 17, 2019 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (kmd)
Jul 17, 2019 1 Main Document (6)
Docket Text: COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2687974.) - filed by Novartis Pharma AG, Eisai Co., Ltd., Eisai Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(kmd) Modified on 7/17/2019 (kmd).
Jul 17, 2019 1 Complaint* (1)
Menu